摘要
肠易激综合征(IBS)是一种常见的以腹痛/腹部不适伴排便习惯改变为特征的功能性肠病,缺乏形态学和生化学改变的生物学标志。IBS的发病机制迄今仍不明确,现在普遍认为是多种因素综合作用的结果,其中心理、精神、社会和环境等因素在发病过程中起重要作用,同时受神经系统、免疫系统和内分泌系统的制约,导致肠道平滑肌运动障碍和内脏感觉异常。在此基础上,当机体受到某些诱因刺激时就会引起肠道易激和过激的功能反应,导致一系列临床症状。其症状发生的直接机制是基于肠道高敏感性和高反应性基础上的肠道运动功能异常。本文通过文献回顾了IBS的发病、致病机理、诊断治疗及几种主要胃肠激素和肥大细胞在IBS致病作用的研究。
临床研究通过应用疏肝健脾安神和胃法为组方的康泰方治疗肝郁脾虚型腹泻型IBS患者,进行临床疗效的评估及应用免疫组化检测治疗前、后结肠粘膜肥大细胞表达与SP、VIP、iNOS、HO-1的表达和RT-PCR法检测iNOS、HO-1mRNA的表达,实验证实了疏肝健脾安神和胃法可能通过调控神经-内分泌-免疫调节网络中的肥大细胞和多种胃肠激素而改善临床症状的。
目的:
1、通过检测肝郁脾虚型腹泻型肠易激综合征患者结肠黏膜iNOS、VIP、SP、HO-1,HO-1mRNA、iNOSmRNA的表达情况及肥大细胞(MC)数量和脱颗粒状况,探讨在肝郁脾虚型腹泻型肠易激综合征发病中的作用和相互关系。2探讨中药康泰方通过影响肝郁脾虚型腹泻型肠易激综合征患者结肠粘膜iNOS、VIP、SP、HO-1,HO-1mRNA、iNOSmRNA的表达情况及肥大细胞(MC)数量和脱颗粒状况而起到治疗作用的可能机理。
方法:
1、筛选出15名健康志愿者作为健康对照组和63名合格的肝郁脾虚型腹泻型肠易激综合征病例,随机分为康泰方治疗组和得舒特对照药物治疗组,分别给予康泰方和对照药物得舒特治疗,疗程为八周。进行两组治疗前、后临床疗效的评估及对17例康泰方治疗组和16例对照药物治疗组治疗前、后取得了结肠粘膜标本,保留结肠粘膜标本。2、以免疫组化的方法分别检测健康对照组及康泰方治疗组、对照组治疗前、后结肠粘膜肥大细胞(MC)数量和脱颗粒状况及iNOS、VIP、SP、HO-1的表达。3、以RT-PCR的方法检测健康对照组及康泰方治疗组、对照组治疗前、后结肠粘膜HO-1mRNA、iNOSmRNA的表达情况。
结果:
1、中药康泰方治疗肝郁脾虚型腹泻型IBS总有效率达100%,治疗组的总有效率、痊愈率、显效率均高于对照组。可明显改善IBS的主要临床症状,对照组治疗后腹痛、腹胀、便溏症状较治疗前有所下降,其余各症状积分治疗前后无显著性差异。2、肝郁脾虚型腹泻型IBS结肠粘膜肥大细胞密度及肥大细胞脱颗粒密度以及同时的免疫组化检测SP、VIP、HO-1的表达较正常健康对照组明显增高,iNOS较正常健康对照组明显减低;通过多因素相关因素分析发现肝郁脾虚型腹泻型IBS的主要中医证候和症状,如腹痛、腹胀、便溏、大便不尽感与结肠粘膜肥大细胞密度及肥大细胞脱颗粒密度以及同时的免疫组化检测SP、VIP、HO-1的表达成明显正相关,与iNOS的表达呈负相关。对照组主要中医证候和症状和结肠粘膜肥大细胞密度及肥大细胞脱颗粒密度以及SP、VIP、iNOS、HO-1的表达也存在一定的相关性。3、肝郁脾虚型腹泻型IBS治疗组治疗前和对照组治疗前与正常健康对照组比较,结肠粘膜iNOS、HO-1mRNA的表达呈显著性差异,并与相应的结肠粘膜iNOS、HO-1的表达呈正相关。
结论:
1、疏肝健脾中药康泰方可明显改善IBS的主要临床症状,在改善心烦失眠、大便不尽感、神疲乏力及胃纳减少等主要中医证候和症状上优于对照组,且没有明显不良反应。2、中药康泰方的应用肝郁脾虚型腹泻型IBS的主要中医证候和症状的改善也同时伴有结肠粘膜肥大细胞密度及肥大细胞脱颗粒密度以及同时的免疫组化检测SP、VIP、HO-1的表达的明显下降和iNOS的升高,并也成正相关关系,而对照组治疗后主要中医证候和症状和结肠粘膜肥大细胞密度及肥大细胞脱颗粒密度以及SP、VIP、iNOS、HO-1的表达也存在一定的相关性。
Irritable bowel syndrome is a common functional gastroenteropathy which is the characteristics of abdominal pain/abdominal discomfort and bowel evacuation habit,is short of change of morphology and biochemics.Its pathogenesis isnot clear so far.Now generally agreed that a lot of factors play an important role in clausing smooth muscle dyskinesia and visceral paresthesia,specifically mentality,psyche,society and circumstances,ect.This article reviews the onset,pathopoiesis,diagnosis and treatment of IBS,and relatted to gut hormones and MC to IBS.This clinical study proves Kangtai Fang can improve clinical symptoms by regulating MC and SP、VIP、iNOS、HO-1,ect gut hormones of neuroendocrine-immunization regulating network.
Objective:
1.By identifying the expression of iNOS,VIP,SP,HO-1,HO-1mRNA,iNOSmRNA and the quantity and degranulation of Mast Cells(MC),to explore the pathogenesis and correlation of irritable bowel syndrome(IBS) with stagnation of liver-QI with deficiency of the spleen and diarrhea.
2.By identifying the effectiveness of TCM-Kang Tai Fang to influence the expression of iNOS,VIP,SP,HO-1,HO-1mRNA,iNOSmRNA and the quantity and degranulation of MC of IBS patients with stagnation of liver-QI with deficiency of the spleen and diarrhea,to explore the possible treatment mechanism of Kang Tai Fang.
Methods:
1.Screening 15 healthy volunteers as the Control,and 63 qualified irritable bowel syndrome patients with stagnation of liver-QI with deficiency of the spleen and diarrhea randomly grouped as Kang Tai Fang Treatment Group and Dicetel Contrast Group,which are administrated with Kang Tai Fang and Dicetel for 8 weeks,respectively.Record the assessment result of medication effectiveness before and after treatment,obtain and preserve the specimen of colon mucosa of both Kang Tai Fang Treatment Group and Dicetel Contrast Group before and after medication administration.
2.Identify the quantity and degranulation of MC and iNOS,VIP,SP,HO-1 expression of the Control,Kang Tai Fang Treatment Group and Dicetel Contrast Group through immunohistochemistry before and after medication administration.
3.Identify HO-1mRNA、iNOSmRNA expression of the Control,Kang Tai Fang Treatment Group and Dicetel Contrast Group through RT-PCR before and after medication administration.
Results:
1.The total effective rate of TCM-Kang Tai Fang is 100%.The total effective rate,cure rate and apparent rate of Kang Tai Fang Treatment Group is significantly higher than Dicetel Contrast Group.TCM-Kang Tai Fang can actively improve the main clinical symptoms of IBS patients,and for Dicetel Contrast Group patients,stomachache,abdominal distension and loose stool can be improved by Dicetel,but others have no obvious improvement.
2.Compared to the Control,the IBS patients' MC density and MC degranulation density,as well as the expression of VIP,SP,HO-1 are significantly increased, iNOS expression is significantly decreased.According to multi-reasons analysis,the positive correlation between IBS patients' indications and symptoms,such as stomachache,abdominal distention,and loose stool,and the MC density,MC degranulation density,the expression of VIP,SP,HO-1,iNOS is found.For Dicetel Contrast Group patients,the correlation between these aspects is still proved.
3.Compared with the Control,the expression of iNOS and HO1mRNA of Kang Tai Fang Treatment Group patients and Dicetel Contrast Group patients is significantly different before and after medication treatment,which is related to the expression of iNOS and HO-1.
Conclusions:
1.TCM-Kang Tai Fang can significantly improve IBS patients' main clinical symptoms without any obvious adverse reaction and its curative effect of improving upset and insomnia,loose stool,debilitation,poor appetite,etc is better than Dicetel.
2.For Kang Tai Fang Treatment Group patients,the MC density and MC degranulation density,as well as the expression of VIP,SP,HO-1 are significantly increased,and iNOS expression is significantly decreased.The correlation is positive.In addition,Dicetel can actively play arole on IBS patients' symptoms and indications,MC density,MC degranulation density,and the expression of VIP,SP,HO-1 and iNOS.
引文
[1]Silk,DBA.Management of irritable bowel syndrome:start of a new era?[J].European Journal of Gastroenterology & Hepatology,2003,15(6):679.
[2]Dunl OP,Simon P,SPiller,et al.Nutritional issues in irritable bowel syndrome[J].Current Opinion in Clinical Nutrition &Metabolic Care,2001,4(6):537.
[3]Moore Comunications,Inc.Break through in Patient Care for Irritable Bowel Syndrome[symposium update][M].FortLaude rale,Fla:Glaxowellcome,2000.
[4]王伟岸,钱家鸣,潘国宗.肠易激综合征的发病机制[J].胃肠病学和肝病学杂志,2001,10(6):99.
[5]Garakani,Amir,Win,et al.Comorbidity of Irritable Bowel Syndrome in Psychiatric Patients:A Review.American journal of Therapeutics[J].2003,10(1):61.
[6]Goroll AH,Mulley jr A.Primary Care Medicine[M].4 thed Philadelphia:LIPP in cottwilliams & Wilkins,2000,485.
[7]Da Poigny,Michel,Bellanger,et al.Irritable bowel syndrome in France:a conunon,debilitating and costly disorder[J].European journal of Gastroenterology&Hepatology,2004,16(10):995.
[8]潘国宗,鲁素彩,柯美云,等.北京地区肠易激综合征的流行病学研究:一个整群、分层随机的调查[J].中华流行病学杂志,2000,21:26.
[9]熊理守,陈惠新,许岸高等.广东省社区人群肠易激综合征的流行病学研究[J].中华医学杂志,2004,84(4):278-281
[10]Hungin AP,W horwell PJ,Tack J,et al.The prevalence,patterns and im pact of irritable bowel syndrome:an intern ational survey of 40,000subjects[J].Aliment Pharmacol rher,2003,17:643-650.
[11]Schnrich S,Dembski R,Resch,et al.Analyzing the content of outcome measures in clinical trials on irritable bowel syndrome using the international classification of functioning,disability arid health as a reference[J].Rehabilitation(Stuttg),2006,45:172-180.
[12]Longstreth GF,Thompson WG,Chey WD,et al.Functional bowel disorders[J].Gastroenterology,2006,130:1480-1491
[13]Drossman DA,Corazziari E,Delvaux M,Spiller RC,et al.RomeⅢ:The functional gastrointestinal disorders[M].Third Edition(KS).Alien Press,Inc,2006,492
[14]许国铭,李石.现代消化病学[M].北京:人民军医出版社,1999,860.
[15]Corney RH,Stanton R.Physical symptom severity,Psychological and social Dysfunction in a series of outpatients with irritable bowel syndrome[J].J Psychosom Res,1990,34:483.
[16]Garakani,Amir,Win,et al.Comorbidity of irritable bowel syndrome in psychiatric patients:A Review[J].American Journal of Therapeutics,2003,10(1):61
[17]崔桂淑.肠易激综合征发病机制的研究现状及进展[J].中国煤炭工业医学杂志,2002,5(9):865
[18]邹多武,董文珠,李兆申,等.肠易激综合征患者内脏高敏感性与肥大细胞的关系[J].第一军医大学学报,2003,24:143
[19]项柏康.重视肠易激综合征发病机理的研究及中医药治疗[J].浙江中医学院学报,2000,24:15.
[20]Small PK,London MA,Han CM,et al.Large scale ambulatory study of post prandial jejunal motility in irritable bowel syndrome[J].Scand J Gastroenterol,1997,32:39
[21]King TS,Elia M,Hunter J.Evidence for abnormal fermentation in the irritable bowel syndrome[J].Lancet,1998,352:1187
[22]Distefano M,Strochi A,Malservise S,et al.Non-absorbable antibiotics for managing intestinal gas production and gas related symptoms[J].Aliment pharmacol Ther,2000,14:1001
[23]李定国,李兆东.肠易激综合征研究现状与展望[J].中华消化杂志,2001,21(2):69
[24]Neal KR,Hebden J,Spiller R.Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factor s for development of t he irritable bowel syndrome:postal survey of patients[J].BMJ,1997,314:779-782.
[25]Dobronte Z,Lakner L,Satang K.Postinfectious irritable bowel syndrome[J].Orv Hetil,2006,147:2077-2080.
[26]Ji S,Park H,Lee D,et al.Postinfectious irritable bowel syndrome in patients with Shigella infection[J].J Gastroenterol Hepatol,2005,20:381-386.
[27]Barbara G,Vallance BA,Collins SM.Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice[J].Gast roenterology, 1997,113:1224-1232.
[28]Gerards C,Leodolter A,Glasbrenner B,et al.H.Pylori infection and visceral hypersensitivity in patients wit h irritable bowel syndrome[J].Dig Dis,2001,19:170-173.
[29]Vergnolle N,Renaux B,Hollenberg MD,et al.Role of rat mast cell protease-2 in intestinal transport and barriar function.Gastroenterology,1998,114(suppl):A674.
[30]Hebden JM,Erah PO,Blackshaw PE,et al.Increased small bowel but not colonic permeability in post-infectious irritable bowel syndrome[J].Gastroenterology,1998,114(suppl):A429.
[31]Jin J,Misra S,Makhlouf M et al.Functional difference between SP and NKA:relaxation of gastric muscle by SPis mediated by VIP and NO[J].Am J Physiol Gastrointest Liver Physiol,Apr 1993,264:678—685
[32]Simon J,Gibbons,Gianrico Farrugia.The role of carbon monoxide in the gastrointestinal tract[J].Physiol,Apr 2004,556:325～336
[33]Kuwahara K,Kitsukawa Y.Suzuki Y,et al.Effects of several endothelin receptor antagonists on gastrointestinal transit of guinea pigs[J].Dig Dis Sci,2000,45(5):960～6
[34]Gershon MD.Endothelin and the development of the enteric nervous system[J].Clin Exp Pharmacol Physiol,1999,26(12):985～8
[35]Konturek SK,Kturek PC.Role of nitric oxide in the digestive system[J].Digestion,1995,56(1):1～13
[36]Stark ME,Szurszewski JH.Role of nitric oxide in gastrointestinal and hepatic function and disease[J].Gastroenterology,1992,103(6):1928～49
[37]Winter BYDe,Boeckxstaens GE and Man JGDe et al.Effect of adrenergic and nitrergic blockade on experimental ileus in rats[J].Pharmacol,1997,120(3):464～468
[38]穆标,王邦茂等．一氧化氮与胃肠动力和功能性疾病[J]．胃肠病学和肝病学杂志,2003,12(4)：322～325
[39]Chey WY,Jin HO,Lee MH et al.Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea[J].Gastroenterol,2001,96(5):1499～506
[40]Roberts-Thomson IC,Fettman MJ,Jonsson JR et al.Responses to cholecystokinin octapeptide in patients with functional abdominal pain syndromes[J].Gastroenterol Hepatol,1992,7(3):293-297
[41]Miwa J,Echizen H,Matsueda K et al.Patients with constipation predominant irritable bowel syndrome(IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea predominant patients and subjects with normal bowel habits[J].Digestion,2001,63(3):188-194
[42]詹丽杏,邹多武,等.测定两型IBS患者血浆5-HT及其代谢产物(5-HIAA)浓度的改变[J].胃肠病学,2001,6(增刊):78
[43]孙刚,杨云生,等.肠易激综合征大鼠模型5-羟色胺能神经通路的研究[J].基础医学与临床,2003,23(增刊):98-99
[44]范红,万萍,何旭,等.胆囊及奥狄氏括约肌功能紊乱与IBS的相关性研究[J].中国肛肠病杂志,2000,20(7):11
[45]贾勇,王巧民,戴海明,等.肠易激综合征T淋巴细胞亚群变化及其意义[J].临床消化杂志,2002,14(2):60-61
[46]张茹,张秀华,孙孟类,等.肠易激综合征血清中IL-8和TNF-α的变化及意义[J].中华腹部疾病杂志,2004,4(1):7-10
[47]Stead RH.Innervation of mucosal immune cells in the gastrointestinal tract[J].Reg Immunol,1992,4(2):91-99
[48]Oliver MR,Tan DT,Scott RB et al,Colonic motor response to IGE-mediated mast cell degranulation in the Hooded-Lister rat[J]..Neurogastroenterol Motil,1996,8(2):121-130
[49]Wood JD.Khin J.Neurotransmission at the interface of sympathetic and enteric divisions of the autonomic nervous system[J].physiol,1999;42(4):201-210
[50]邹多武,董文珠,李兆申,等.肠易激综合征患者内脏高敏感性与肥大细胞的关系[J].第一军医大学学报,2003,24(2):143-146
[51]李青,王梅艳,吕国节,等.腹部冷刺激对肠易激综合征患者内脏感觉阈值的影响[J].胃肠病学和肝病学杂志,2002,11(4):339-341
[52]Hasler A,Koursarakos P,Patsopoulos D,et al.increased prevalence of irritable bowel syndromein patients with bronchial asthma[J].Respir Med.2003,97(1):75-79
[53]Manning,A.P,ThomPson,W.G,Heaton,K.W,et al.Towards a positive diagnosis Of the irritable bowel[J].BMJ,1978,2:633.
[54]KruisW,ThiemeC,WeinzierlM,et al.A diagnostic score for the irritable Bowel syndrome.Its value in the exclusion of organic disease[J].Gastroenterology,1984,87:1-7.
[55]Drossman DA.US Natlonal Prevalences of Functional Gastrointestinal Disorders,in Drossman DA(Ed.):The Functional Gastrointestinal Disorders:Diagnosis,PathoPhysiology and Treatment.Boston:Little,Brownand Co,1994,8:311-328.
[56]Drossman DA.The functional gastrointestinal disorder sand the Rome Ⅱproce 5.GUT45(SUPPL.11) 111-115,1999.
[57]Longstreth GF,Thompson WG,Chey WD,Houghton LA,Mearin F.Spiller RC.Funotional bowel disorder[J].Gastroenterology,2006,130:1480-1491.
[58]Drossman DA,Morris CB,HuY,et al.A ProsPective assessment of bowel habit in irritable bowel syndrome in women:defining an alternator[J].Gastroenterology,2005 Mar;128(3):580-9.
[59]王伟岸,何剑琴,胡品津,等.心理社会因素对肠易激综合征患者生活质量的影响[J].世界华人消化杂志,2004,12:1626-1630
[60]El—SeragHB,OldenK,Bjorkman D.Health relate quality of life among Person with irritable bowel syndrome:a system a ticre view[J].Aliment Ther,2002,16:1171-1185.
[61]HB.Im Pact of irritable bowel syndrome:prevalence and effect on health —related quality of life[J].Rev Gastroenterol Disord,2003,3:53-11.
[62]Muller—LissnerS,KochG,TalleyNJ,etal.Subject' s global assessment of relief:an a ProPriate method to assess the impact of treatment on irritable bowel syndrome—related symptoms in clinical trials[J].J Clin EPidemiol,2003,56:310-316.
[63]PortincaseP,MoschettaA,BaldassarreG,et al.Panenteric dysmotllity,imPairedquality of life andalexlthymiaina large group of Patlents meeting Roomll criteria for irrltable bowel syndrome[J].World J Gastroenterol,2003,9:2293-2299.
[64]AkehurstRL,BrazierJE,MathersN,etal.Health—related quality of life and cost impact of irritable bowel syndrome in a UK Primary caresetting[J].Pharmacoeconomics,2002,20:455-462.
[65]PatrickDL,DrossmanDA,FrederickIO,et al.with irritable bowel syndrome:Developmentand Quallty of life validation of a new measure[J].Digestive Disease sand sciences,1998,43:400-411.
[66]DianneGroll,StePhenJ.Vanner,WilliamT.DePew,etal.TheIBS—36:A Quality of Life measure or Irritable Bowel Syndrome[J].The American Journal of Gastroenterology,2002,97:962-971.
[67]官坤祥,吴文江.肠易激综合征中医证候量表的建立与评价[J].吉林中医药,2004,24:6-8.
[68]金华锋.试论肠易激综合征的分期论治[J].中医药学报,2000,6:8-9
[69]周福生,程宏辉,祝淑贞.心胃相关理论及临床应用[J].浙江中医学院学报,2004,(02):73-75
[70]张尊敬,刘忠达.肠易激综合征中医治疗研究概况[J].2008,43(6):364-366
[71]吴莉佳.曹蓓加味痛泻方治疗肠易激综合征41例[J].中国医药导报,2007,4(8):1120
[72]王玉保.痛泻要方半夏泻心汤并用治疗腹泻型肠易激综合征41例[J].实用中医内科杂志,2005,19(1):78
[73]王书浩.七味白术散治疗慢性腹泻型肠易激综合征58例[J].江西中医药,2005,36,(9):29
[74]曹福凯,钱峻,金小晶,等.藿香正气散加减方治疗腹泻型肠易激综合征58例观察[J].安徽中医临床杂志,2003,159(5):326
[75]李新一.自拟抑肝扶脾汤治疗腹泻型肠易激综合征32例[J].北京中医,2005,24(6):328-329
[76]弋巧玲,李富增.加味胃风汤治疗肠易激综合征腹泻型33例[J].中医研究,2005,18(3):39
[77]陈伟,余龙龙.肠激宁治疗腹泻型肠易激综合征临床观察[J].实用中医药杂志,2007,23(3):148-149
[78]刘晓辉.合欢逍遥颗粒治疗腹泻型肠易激综合征的临床观察[J].辽宁中医药大学学报,2006,8(4):91
[79]吕丹杨.藿香正气软胶囊治疗肠易激综合征58例临床观察[J].浙江中医杂志,2004,39(7):308-309
[80]杜中良。焦玉坤,张银华.谷参肠安治疗腹泻型肠道易激综合征38例临床观察[J].中国综合临床2002,18(7):591-592
[81]庄彦华,杨春辉,杨旭东,等.中药神曲对肠易激综合征患者肠道菌群的调节和临床疗效的研究[J].中国微生态学杂志,2005,17(1):41
[82]许引兴.黄连素治疗腹泻型肠易激综合征疗效观察[J].现代中西医结合杂志,2007,16(5):616
[83]傅怀丹,蔡国伟.辨证分型针灸治疗肠易激综合征40[J].中国针灸,1993,(3):56
[84]刘鼎清,蔡连红.艾灸治疗肠易激综合征30例[J].中国针灸,1992,(6):2.
[85]王景辉,吴焕金,陈汉平.隔药灸治疗肠易激综合征28例[J].上海针灸杂志,1991, 14(1):6.
[86]郑培奋,张杰.中西医结合治疗肠易激综合征[J].浙江中西医结合杂志,1999,9(6):371.
[87]孙冰,刘国惠.逍遥丸配合心理治疗肠易激综合征对照研究.中国中西医结合杂志,1998:18(8):494.
[88]李素青.中西药灌肠治疗肠易激综合征的对比观察[J].中医杂志,1993,(1):39.
[89]孙国范,林吉品.水针治疗结肠肝脾曲综合征10例[J].上海针灸杂志,1985,(1):3.
[90]陆亚康.毫米波并耳压治疗肠易激综合征48例[J].中国中西医结合杂志,1998,18(6):378.
[91]T.Sonoda,Y.Kitamura,Y.Haku,H et al.Mast-cell precursors in various haematopoietic colonies of mice produced in vivo and in vitro[J].Br J Haematol,1983,53(4):611-620
[92]Bischoff,G.Sellge.Mast cellhyperplasia:Role ofcytokines[J].Int Arch Allergy Immunol,2002,127(2):118-122.
[93]Barbara G,Stanghellini V,De Giorgio R,et al.Functional gastrointestinal disorders and mast cells:implications for therapy[J].Neurogastroenterol Motil,2006,18:6-17
[94]R.B.Hiatt and L.Katz.Mast cells in inflammatory conditions of the gastrointestinal tract[J].Am J Gastroenterol,1962:37:541-545
[95]G.Barbara,R.De Giorgio,V.Stanghellini,et al.New pathophysiological mechanisms in irritable bowel syndrome[J].Aliment Pharmacol Ther,2004,20(Suppl 2):1-9.
[96]G.Barbara,V.Stanghellini,R.De Giorgio,et al.Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome[J].Gastroenterology,2004,126(3):693-702.
[97]李兆申,董文殊,邹多武,等.肠易激综合征肠粘膜肥大细胞的实验研究[J].解放军医学杂志,2002,27(7):628-631
[98]Mar Guilarte,Javier Santos,Ine's de Torres.Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum[J].Gut 2007,56:203-209
[99]Addolorato G,M arsigli L,Capristo E et al.Anxiety an d depression:acorllrllon feature of health care seeking patients with irritable bowel syndrome an d food allergy[J].Hepatogastroenterology,1998,45(23):1559
[100]H.Serna,M.Porras and P.Vergara.Mast cell stabilizer ketotifen prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat[J].J Pharmacol Exp Ther,2006,319(3):1104-1111.
[101]Iovino P,Azpim F,Dimingo E,et al.The sympathetic nervous system modulates perception and reflex reponaes to gut distensilnin human[J].Gastroenterology,1995,108
[102]Coelho AM,Fiarnonti J,Buem L.Systemic lipolysacacchaide influences rectal sensitivity in rats:role of mast cells,cytokines,and vagus nerve[J].Am J physiol,2000,279:G781.
[103]Hebden JM,Erah DO,Blackshaw PE,et al.Increased small bowel butnot colonic permeablity in post—infectious irritable bowel syndmme [J]Gastroenterology,1998;114(suppl):A429
[104]Oliver MR,Tan DTM,kirk DR.et al.Colonic and jejunal motordiaturbancea after colonic antigen challenge of sensitized rat[J].Gastroeaaterology,1997,112(6):1996.
[105]Codho,AM.Fiormnonti J,Bueno L.Mast celI degranuiafion induce delayed riced aliodynla in rats:role of histamine and 5—HT[J].Dig Dis Sd,1998,43(4):727
[106]王伟岸.肠道炎症后的IBS[J].国外医学内科分册,1996,26(3):93-96,110
[107]Gui X—Y.Mast cells:A possible link between psychological stress,enteric infection,food allergy and gut hypersensitivity in the irritable bowel syndrome[J].J Gastroenterology and Hepatology,1998,13:980-9
[108]黄绍刚.肝脾失调在IBS内脏高敏感性发生中的作用及其机制[J].中国中医基础医学杂志,2008,14(7):530
[109]刘珊珊,陶双友,王汝俊.胃肠激素和肥大细胞与肠易激综合征发病的关系[J].现代中西医结合杂志,2006,15(23):3310-3312
[110]Bouhnik Y,Neut C,Raskine L,et al.Prospective,randomized,parallel —group trial to evaluate the e—fleets of lactulose and polyethylene glycol—4000 on colonic flora in chronic idiopathic constipation[J].Alime Phann&Thera,2004,19(8):889-899
[111]Goldberg PA,Kamm MA,Setti.Carraro P,et al.Medification of visceral sensitivity an d pa in in IBS by 5—HT3 an tagonism(ondan setron)[J].Digestion,1996,57(6):478-83
[112]Talley,NJ.Serotoninergic neuroenteric modulators[J].Lancet,2001.358 (9298):2061—8
[113]Talley NJ,Phillips SF,Haddad A.GR38032F(ondansetron),a selective 5.HTs receptor an tagonist,slows colonic transit in heal thy[J].Dig Dis Sei,1990,35(4):477—80
[114]Gore S,GilmoreIT,Haigh CG etal.Colonictransitinmallis slowed by ondansetron(GR38032F),a selective 5-hydroxytryptamine receptor(type 3) antagonist[J].Aliment Pharmacol Ther,1990,4(2):139—44
[115]Miwa J,Echizen H,Matsueda K et al.Patients with constipationpredominant irritable bowel syndrome may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits[J].Digestion,2001,63(3):188—94
[116]H.Mommikes,J.J.bbe,M.Hildebrandt.et al.Role of stress in functional gastrointestinal disorders[J].Dig Dis,2001,19(3):201—11
[117]Fukudo S,Nomura J,Hongo M.Impact of coicotropin—releasing hormone on gastrointestinal motility and adronoc orticotropic horm one in normal controls and patients with irritable bowel syndrome[J].Gut,1998,42(6):845—9
[118]Monnikes H,Schmidt BG.Tache W.Psychological stress—induced accelerat.ed colonic transit in rats involves hyrothalamic corticotropinreleasing factor[J].Gastroenterology,1993,104(3):716—22
[119]Tache Y,Martinez V,Million M,et al.Corticotropin-releasing factor and the brain。gutmotor response to stress[J].Can J Gastroenterol,1999,13(suppl)22
[120]Said S1,Mutt V.Polypeptide with brological activity:isolation from small intestine[J].Science,1970,169:1217
[121]Wang Yun Xia,Michase J.Purification and struchral characterization of vasoaction intestinal polypeptide from the tront and bowfin[J].General comparative endocrinology,1995,98(1):94
[122]Ransj Lie,Mukohyama et al.Microsolated mouse osteodasts express VIP-1[J].Bioche Bichy Research Commun,2000,274(2):400
[123]Uessks,Yano,Yamesaki,Somatostatin,vasoactive,intestinal,peptide ranulin-like peptides isolated m intestinal entracts of goldifish,Crassius[J]Gene Comparation Endocrinology,1995,99(3):298
[124]Candi P,Bouvineau A,Maoret JJ.Mutational analysis of cysteine resides within the extracellular domains of the human vasoactive intestinnal peptide(VIP) Ⅰ receptor iddentifies seven,mtants that are defective in VIP binding gandin[J].Bio Biop Rese Comm,1995,211(3):901
[125]Edward J,Derek R,Jeffrey LK.Specific recongnition of the human neumendocriences[J].2000,15(5):465
[126]周吕.肠神经系统脑肠肽[J].中华消化杂志,1996,16(5):287-290
[127]Morise K,Furuaswa A,Yanmmoto H,et al.Role of gut hormones irritable bowel syndrome[J].Nippon Rinsho,1992,50(11):2697-2705
[128]Simren M,Abrahamsson H,Bjornsson ES.An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome[J].J Gut,2001,48(1):20-27
[129]谢勇.肠易激综合征乙状结肠粘膜内胃肠激素及NO的变化[J].中国内镜杂志,1997,3(6):17-18
[130]李兆申,董文珠,邹多武,等.肠易激综合征肠粘膜SP、VIP、CGRP变化的研究[J].第二军医大学学报,2003,24(2):147-150
[131]Gui XY.Mast cells:A possible link between psychological stress,enteric infection,food allergy and gut hypersersitivity in the IBS[J].J Gastroenterology and hepatology,1998,13:980-989
[132]Coeibo AM,et al.Mast cell degradulation induce delayed rectal alledijnia in rats:role Of histamine and 5—HT[J].Dig Dis Sci,1988,43(4):727-737
[133]Pryor WA,Houk KN,Foote CS,et al.Free Radical Biology and Medicine:It's a Gas,Man![J].Am J Physiol Regul Integr Comp Physiol,2006:203
[134]Kim HP,Ryter SW,Choi AM.CO as a cellular signaling molecule[J].Annu Rev Pharmacol Toxical,2006,46:411-449
[135]Elbirt K K Bonkovsky H L.Heme oxygenase:recent advances in understanding its regulation and role[J].Proc Assoc Am Physicians,1999,111(5):438-447.
[136]Morse D,Sethi J.Carbon monoxide and human disease[J].Antioxid Redox Signal,2002,4:331-338.
[137]Hartsfield CL.Cross talk between carbon monoxide and nitric oxide[J].Antioxid Redosc Signal,2002,4:301-307.
[138]Rattan S.The internal anal sphincter:regulation of smooth muscle tone and relaxation[J].Neurogastroenterol Motil,2OO5,17Suppl 1:50-59
[139]Kadinov B,Itzev D,Gagov H,ect.Introduction of heme oxygenase in guinea-pig stomach:roles in contraction and in sigle muscle cell ionic currents[J].Acta Physiol Scand,2002,175:297-313
[140]Soares MP,Usheva A,Brouard S,et al.Modulation of endothelial cell apoptosis by heme oxygenase—1—derived.carbonmonoxide[J].Antioxid Redosc Signal,2002,4:321～329.
[141]Gibbons SJ,Farrugia G.The role of carbon monoxide in the gastrointestinal tract[J].J Physiol,2004,556:325-336
[142]Farrugia G,LeiS,Lin X,ec al.A major role for carbon monoxide as an endogenous hyperpolaizing factor in the gastrointestinal tract[J].Proc Natl Acad Sci USA,2003,100:8567-8570
[143]Suematsu M,Kashiwagi S,Sano T,et al.Carbon monoxide as an endogenous moduletor Of hepatic vascular perfusion[J].Biochem Bio phys Res Commun,1994,205:1333～1337.
[144]Durante W,Peyton KJ,Schafer Al,et al.Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells[J].Arterioscler Thromb Vasc Biol,1999,19:2666-2672
[145]Piotrowska AP,Solari V,de Caluwe D,et al.Immunocolocalization of the heme oxygenase-2 and interstitial cells of Cajal in normal and aganglionic colon[J].J Pediatr Surg,2003,38:73-77
[146]Liu DN,He ZY,Fang Y,et al.Heme oxygenase-1 and carbon monoxide are key mediators for vascular smooth muscle cells proliferation induced by insulin-like growth factor-1.Zhonghua Xinxueguanbing Zazhi,2006,34:153-158
[147]Foresti R,Motterlini R.The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis[J].Free Radic Res,1999,31:459-475
[148]Nakao A,Kimizuka K,Stolz DB,et al.Protective effect of carbon monoxide inhalation for cold-preserved small intestinal grafts[J].Surgery,2003;134:285-292
[149]Moore BA,Otterbein LE,Turler A,et al.Inhaled carbon monoxide suppresses the development of postoperative ileus in the murine small intestine[J].Gastroenterology,2003,124:377-391
[150]Miller SM,Farrugia G,Schmalz PF,et al.Haem oxygenase in enteric nervous system of human stomach and jejunum and co-localization with nitric oxide synthase[J].Neurogastroenterol Motil,2001,13:121-131
[151]Murthy S,Flanigan A,Coppola D,et al.A locally active TNF inhibitor,is effective in the dextran sulphate mouse model of chronic colitis[J].Inflamm Res,2002,51:522-531
[152]Berberat PO,A-Rahim YI,Yamashita K,et al.Heme oxygenase-1-generated biliverdin ameliorrates experimental murine colitis[J].Inflamm Bowel Dis 2005,11:350-359
[153]Scott JR,Gray DK,Bihari A,et al.Heme oxygenase modulates small intestine leukocyte adhesion following hindlimb ischemia/reperfusion by regulating the expression of intercellular adhesion molecule-1[J].Crit Care Med 2005;33:2563-2570
[154]Ping W,Qizi Y,Hesheng O,et al.Endogenous heme oxygenase/carbon monoxide system mediates lipopolysaccharide-induceed intussusception in rats[J].Chin Med Sci J,2000,15:89-92
[155]Hegazi RA,Rao KN,Mayle A,et al.Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway[J].J Exp Med 2005,202:1703-1713
[156]Leffler CW,Balabanova L,Fedinec AL,et al.Mechanism of glutamate stimulation of CO production in cerebral microvessels[J].Am J Physiol Heart Circ Physiol,2003,285:H74-80
[157]Boehning D,Moon C,Sharma S,et al.Carbon monoxide neurotransmission activated by CK2 Phosphorylation of heme oxygenase-2[J].Neuron,2003,40:129-137
[158]Van Ginneken C,Van Meir F,Sys S,et al.Stereologic description of the changing expression of constitutive nitric oxide synthase and heme oxygenase in the enteric plexuses of the pig small intestine during development[J].J Comp Neurol,2001,437:118-128
[159]Rattan S,Regan RF,Patel CA,et al.Nitric oxide not carbon monoxide mediates nonadrenergic noncholinergic relaxation in the murine internal anal sphincter[J].Gastroenterology,2005,129:1954-1966
[160]周福生,吴文江,黄志新.顺激合剂治疗肠易激综合征综合疗效观察[J].广州中医药大学学报,2002,12(4):269
[161]Kinobe R,Ji Y,Nakatsu K,et al.Peroxynitrite-mediated inactivation of heme oxygenases[J].BMC Pharmacol,2004,4:26
[162]Cherner JA,Jensen RT,Dubo is A,et al.Gastrointestinal dysfunction in systemic mastocyosis[J].Gastroenterology,1988,95:657-67
[163]Gwee KA,Graham JC,Mckendrick MW,et al.Psychometric scores and persistenceof irritable bowel after infectious diarrhoea[J].Lancet,1996,347:150-3
[164]Weston A,Biddle W,Bhatia P,etal.Terminal ileal mucosal mast cells in irritable bowel syndrome.Dig Dis Sci,1993,38:1590-5
[165]扬云生,周殿元,张万岱,等.肠易激综合征回盲部肥大细胞研究[J].中华内科杂志,1997,36(4):231-3
[166]GweeKA,LeongYL,Graham C,etal.The role of psychological and biological factors in post infective gut dysfunction[J].Gut,1999,44(3):400-6
[167]Santos J,Saperas E,Nogu eiras,et al.Release of mast cell mediators into the junum by cold pain stress in humans[J].Gastroenterology,1988,114(4):640-8
[168]Bissonnette EY,Hogaboam CM,Wallace JL,et al.Potentiation of tumor necrosis factor—alpha—mediated cytotoxicity of mast cells by their production of nitric oxide[J].J Immunol,1991,147:3060-5
[169]Aggarwal A,cutts rF,Albert TL,et al.Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalittes[J].Gastroenterology,1994,106:945-50
[170]GoodeT,O Connell J,Anton P,et al.Neurokinin—1 receptor expression in inflammatory bowel disease:molecular quantitation and localisation[J].Gut,2000,47(3):387-96
[171]Wheatley JM,Hutson JM,Hurley MR el al.Slow—transit constipation in childhood[J].Pediatr Surg,1999,34(5):829-32
[172]Dong WZ.Zon DW.Zou XP et al.Study of visceral hypersensitivity in irritable bowel synmmune[J].Chin J Dig Dis,2004,5(3):103-9
[173]Jin J,Misra S,Mhlouf M,et al.Funelional difence betwecn SP and NKA:relaxation of gastric muscle by SPis mtliated by VIP and NO[J].Am J Physiol Castroentest liver physiol,1993.264:678-685
[174]Simon J,Gibbons.Gianrico Farrugia.the role of caFlR)nmonoxide in the gastmintestinal tract[J].Physiol,2001,(4)556:325-336
[175]Simrrn M,Abrah unsson.An exaggerated sensory component of the gastmintestinal response in patients with irritable bowel syndrome[J].Gut,2001,48(1):20-27
[176]陈芝芸,严茂样,等.肠易激综合征患者血胃肠激素的变化[J].浙江中医学院学报,2000,24(3):18-20
[177]shall V,Lyford G,Gores G,et al.Nitric oxide in gastrointestinal health and disease[J].Gastroenterology,2004,126(3):903.
[178]Morse D,Choi AM.Heme oxygenase-1:the "emerging molecule" hasarrived [J].Am J Respir Cell Mol Biol,2002,27(1):8-16.
[179]Guo iS,Cho CH,Wang WP,et al.Expression and activities of three inducible enzymes in the healing of gastric ulcers in rats[J].World J Gastroenterol,2003,9(8):1767-1771.
[180]Simon J,Gianrico Farrugia,et al.A role of carbon monoxide in the gastrointestinal tract[J].Physiol,2004,556:325.
[181]Fujii H,Takahashi T.et al.Protective role of heme oxygenase-1 in the intestinal tissue injury in an experimental model of sepsis[J].Crit Care Med,2003,31(3):893-902.
[182]Wang W P,Guo x,et al.Prottive role of heme oxygenase-1 on trinitrobenzene sulfonic acid induced colitis in rats[J].Physiol Gastrointest Liver Physiol.2001,281:586.
[183]Satish Rattan,Sushanta Chakder.Influence of Heme Oxygenase Inhibitors on the Basal.Tissue Enzyrrkatic Activity and Smooth muscle Relaxation of Intemal Anal Sphincter[J].Pharmacol,2000,294:1009.
[184]Li X,Clark JD.Heme oxygenase type 2 plays a role in formalin-induced nociception[J].Pain,2000,86(1):75-80.
[185]Stark ME.Smewski JH.Role of nitric oxide in gastrointestinal and hepatic function and disease.Gastroenterology,1992,103(6):1928-49
[186]Winter BY De,Boeckxstaens GE and Man JG et al.Effect of adrenergic and nitrergic blockade on experimental ileus in rats.Phamacol,1997,120(3):464-468